The consumption of certain foods such as oily fish or potatoes influence gene expression in the colon, as found by a research team from Bellvitge Biomedical Research Institute - IDIBELL, Institut Català d'Oncologia (ICO), #CIBER, Hospital Universitari de Bellvitge and Institut d'Investigació Biomèdica de Girona (IDIBGI) More studies would open new paths contributing to the prevention of gastrointestinal conditions such as colorectal #cancer or inflammatory bowel diseases #IBD through diet. https://lnkd.in/dkqmSq-K
Bellvitge Biomedical Research Institute - IDIBELL
Servicios de investigación
L'hospitalet de Llobregat, Barcelona 21.816 seguidores
Research. Innovation. Society.
Sobre nosotros
The Institute of Biomedical Research of Bellvitge (IDIBELL) is a research CERCA center created in 2004. It is participated by the University Hospital of Bellvitge and Viladecans Hospital of the Catalan Institute of Health (ICS), the Catalan Institute of Oncology (ICO), the University of Barcelona and the city council of l'Hospitalet de Llobregat. IDIBELL is located in Hospitalet de Llobregat, is a member of the Campus of International Excellence of the University of Barcelona (HUBc).
- Sitio web
-
http://www.idibell.cat
Enlace externo para Bellvitge Biomedical Research Institute - IDIBELL
- Sector
- Servicios de investigación
- Tamaño de la empresa
- De 1.001 a 5.000 empleados
- Sede
- L'hospitalet de Llobregat, Barcelona
- Tipo
- Organización sin ánimo de lucro
- Fundación
- 2004
- Especialidades
- Biomedicine, Translational research, Cancer y Neurosciences
Ubicaciones
-
Principal
Gran Via de l'Hospitalet, 199
L'hospitalet de Llobregat, Barcelona 08908, ES
-
Carrer de la Feixa Llarga
L'Hospitalet de Llobregat, Catalonia 08907, ES
-
Avinguda de la Mare de Déu de Bellvitge, 3
L'Hospitalet de Llobregat, Catalonia 08907, ES
Empleados en Bellvitge Biomedical Research Institute - IDIBELL
-
Cristina Muñoz-Pinedo
Group leader at IDIBELL - research on cell death and cancer metabolism
-
Aurora Pujol
Professor of Genetics and Neuroscience, MD, PhD, FACMG, Genomic Medicine
-
Josep Gardenyes Bernaus
Equality & Talent - HR - Project Management - Molecular Biology
-
Joan Prades
Cancer policy & healthcare services researcher
Actualizaciones
-
B-ACTIVE: the #seriousgames platform to promote healthy behavior in people with cancer has obtained the best score in the 2nd edition of “The Health Games Incubator” 2024, where 18 international projects were presented. The team is led by Dr Paula Jakszyn (Bellvitge Biomedical Research Institute - IDIBELL & Institut Català d'Oncologia (ICO) and Dr. Jordi Vilaró (Blanquerna - Universitat Ramon Llull). https://lnkd.in/dFu-v3up
B-ACTIVE: serious games platform to promote healthy behavior in people with cancer
https://idibell.cat/en
-
We are pleased to announce our fantastic keynote speakers for the RegenBell 2024 symposium on #StemCells and #RegenerativeMedicine! 📅 21-22 November 2024 📍 Institut d'Estudis Catalans (Carrer del Carme, 47. BCN) ⏳ Remember: this is the last week to send your abstract! ➡ https://lnkd.in/dSA_YBqb for more info, abstract submission and registration
-
We're Hiring! We are currently on the lookout for a Manager for our Accounting Unit. If you're someone with experience managing people, a background in accounting, and valuable experience in research centers, we want to hear from you. https://lnkd.in/dpyz-DjW
-
A new personalized therapy through genomic profiling may improve survival in patients with cancer of unknown primary with an unfavorable prognosis, according to the results of the CUPISCO study, the largest to date on cancer of unknown primary, published in The Lancet. Lead by DKFZ German Cancer Research Center counted on relevant participation of Institut Català d'Oncologia (ICO) and Bellvitge Biomedical Research Institute - IDIBELL https://lnkd.in/dREtT5PY
A new personalized therapy through genomic profiling may improve survival in patients with cancer of unknown primary
https://idibell.cat/en
-
Researchers from Bellvitge Biomedical Research Institute - IDIBELL, CIC bioGUNE, #CIBEREHD and IRB Barcelona demonstrate that iron accumulation is an important factor in the progression of liver #fibrosis and cellular senescence. The study suggests that the administration of iron chelators could be an effective strategy to slow down or prevent liver fibrosis. https://lnkd.in/dB9is9Fv
Iron accumulation and cellular senescence in liver fibrosis: new perspectives on treatment
https://idibell.cat/en
-
"Advances in chemical biology are fueled by multidisciplinarity and teamwork": As a selected voice in the Cell Chemical Biology special 30th anniversary, Dr Albert A. Antolín Hernández from Bellvitge Biomedical Research Institute - IDIBELL and Institut Català d'Oncologia (ICO) highlights the relevance of #multidisciplinarity and #teamwork for the advance of chemical biology research, a relatively new scientific field that is opening new paths in drug discovery and precision medicine. https://lnkd.in/d_SsW377
Advances in chemical biology are fueled by multidisciplinarity and teamwork
https://idibell.cat/en
-
Dr. Maria Molina, our scientific director, has received one of the European Respiratory Society Mid-Career Gold Medals Award, which recognizes both an already consolidated outstanding research career and the work potential still ahead of a respiratory diseases specialist. The award cerimony took place today in Viena #ERS2024. Congratulations! https://lnkd.in/dpDcnNyj
Dr. Maria Molina, IDIBELL scientific director, receives the European Respiratory Society Gold Medal
https://idibell.cat/en
-
For the first time, scientists link air pollution to the use of antibiotics, two of the biggest global public health challenges. In the days when air pollution increased, so did antibiotic prescriptions for acute respiratory symptoms, according to the study based on data from the 11 largest cities in Catalonia. https://lnkd.in/dEQUChAy
For the first time, scientists link air pollution to the use of antibiotics
https://idibell.cat/en
-
SpadaHC: a new database to improve #hereditary cancer genes variants classification in the Spanish population. The tool, developed by IDIBELL, ICO and CIBERONC researchers, facilitates a more precise and uniform genetic variants #classification, a key to making clinical decisions in patients with suspected cancer. https://lnkd.in/dPRvG78T
SpadaHC, a new database to improve hereditary cancer genes variants classification in the Spanish population
https://idibell.cat/en